![logo](/logos/NAVA.OL.webp)
Navamedic ASA
OSE:NAVA.OL
37.3 (NOK) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Navamedic ASA |
Symbool | NAVA.OL |
Munteenheid | NOK |
Prijs | 36.8 |
Beurswaarde | 638,583,040 |
Dividendpercentage | 0% |
52-weken bereik | 31 - 43.9 |
Industrie | Medical Distribution |
Sector | Healthcare |
CEO | Ms. Kathrine E. Gamborg Andreassen |
Website | https://www.navamedic.com |
An error occurred while fetching data.
Over Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (NOK)
Cijfers zijn in miljoenen (NOK)